OPTN
Price:
$9.6
Market Cap:
$97.22M
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmac...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-10-13
Stock Exchange
NASDAQ
Ticker
OPTN
According to OptiNose, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.42. This represents a change of -886.46% compared to the average of 0.56 of the last 4 quarters.
The mean historical PE Ratio of OptiNose, Inc. over the last ten years is -63.03. The current -4.42 PE Ratio has changed 601.83% with respect to the historical average. Over the past ten years (40 quarters), OPTN's PE Ratio was at its highest in in the June 2023 quarter at 196.69. The PE Ratio was at its lowest in in the December 2016 quarter at -340.65.
Average
-63.03
Median
-32.58
Minimum
-268.92
Maximum
34.27
Discovering the peaks and valleys of OptiNose, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.78%
Maximum Annual PE Ratio = 34.27
Minimum Annual Increase = -666.29%
Minimum Annual PE Ratio = -268.92
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.15 | -94.85% |
| 2023 | -61.12 | 2.78% |
| 2022 | -2.12 | -87.45% |
| 2021 | -16.92 | -44.50% |
| 2020 | -30.49 | -42.65% |
| 2019 | -53.16 | 53.32% |
| 2018 | -34.67 | -82.13% |
| 2017 | -194.05 | -666.29% |
| 2016 | 34.27 | -112.74% |
The current PE Ratio of OptiNose, Inc. (OPTN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.13
5-year avg
-22.76
10-year avg
-63.03
OptiNose, Inc.’s PE Ratio is less than Zomedica Corp. (-4.22), less than Five Star Senior Living Inc. (-3.12), less than Upexi, Inc. (-0.26), greater than Societal CDMO, Inc. (-7.89), less than Jounce Therapeutics, Inc. (-1.91), less than Procaps Group S.A. (2.40), less than Miromatrix Medical Inc. (-2.34), less than Asensus Surgical, Inc. (-1.11), less than Aadi Bioscience, Inc. (-2.49), less than Zynerba Pharmaceuticals, Inc. (-1.59),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.22 | $95.35M | |
| -3.12 | $98.39M | |
| -0.26 | $63.95M | |
| -7.89 | $116.13M | |
| -1.91 | $98.95M | |
| 2.40 | $102.08M | |
| -2.34 | $92.95M | |
| -1.11 | $94.92M | |
| -2.49 | $94.89M | |
| -1.59 | $70.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OptiNose, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OptiNose, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is OptiNose, Inc.'s PE Ratio?
How is the PE Ratio calculated for OptiNose, Inc. (OPTN)?
What is the highest PE Ratio for OptiNose, Inc. (OPTN)?
What is the 3-year average PE Ratio for OptiNose, Inc. (OPTN)?
What is the 5-year average PE Ratio for OptiNose, Inc. (OPTN)?
How does the current PE Ratio for OptiNose, Inc. (OPTN) compare to its historical average?